Combo Treatment Provides Relief

A Canadian study of 2760 patients with asthma at 246 centers in 22countries found that combining an inhaled corticosteroid and a long-lastingbeta-2 agonist appeared to provide consistent relief for individuals withasthma. Specifically, there was a 45% lower exacerbation rate with thecombined budenoside/formoterol therapy. The treatment also loweredoverall severe exacerbation levels and delays in exacerbations requiringmedical attention, improved lung function, reduced awakenings at nightbecause of disease, and improved symptom control. (The findings werereported in the American Journal of Respiratory and Critical CareMedicine, January 2005).